By Kawee Chong · Commercialisation & Sourcing · Published 11 Jul 2026
Most brand owners already know, in the abstract, that OEM, ODM and private label are different ways of getting a cosmetic product made. Knowing the definitions doesn’t automatically tell you which one is right for your specific brand, though — and getting the choice wrong at the wrong stage can cost you months of runway or lock you into a formula that’s easy for a competitor to copy.
Rather than repeating the dictionary definitions, this guide works through the practical decision itself: the questions worth asking, the scenarios where each model tends to make sense, and how the right answer often changes as your brand grows.
Key takeaways
- The right model depends less on which is “best” and more on your current budget, timeline pressure and need for differentiation.
- Many brands don’t pick one model for their entire catalogue — they mix private label, ODM and OEM across different SKUs depending on that product’s role.
- The right choice at launch often isn’t the right choice two years later; revisiting the decision as the brand grows is normal, not a sign of a bad initial call.
Start with your budget, honestly
Formulation development cost scales with how custom the product is. Private label typically has the lowest upfront cost because there’s no formulation R&D to fund. ODM sits in the middle. Full custom OEM development usually carries the highest upfront cost because the factory needs to fund a dedicated development, stability testing and validation cycle before the first commercial batch. Before comparing manufacturers, get honest with yourself about how much capital you can commit before you see any revenue, and let that number narrow your options first.
Then factor in your timeline pressure
If you’re trying to catch a specific seasonal window, a trend cycle, or a retail buyer’s onboarding deadline, timeline can override every other consideration. Private label can sometimes reach shelves in a matter of weeks. ODM projects commonly take several weeks to a few months depending on the customisation requested. Full OEM development, especially for a genuinely new formulation, can take several months once you factor in sample rounds, stability testing and documentation. If your deadline is fixed and close, that alone may rule out full OEM for this particular launch.
How much differentiation does this specific product actually need?
Not every SKU in your catalogue needs to be unique. A hero product that anchors your brand identity probably benefits from OEM-level exclusivity. A secondary or seasonal item that exists mainly to round out your catalogue may not need the same investment — a well-customised ODM formula, or even a private label item with strong packaging and positioning, can perform perfectly well. Being honest about which category a given product falls into prevents over-investing in differentiation that customers won’t actually notice or pay a premium for.
Scenario: a solo founder testing a first product concept
For a founder validating demand before committing significant capital, private label or ODM is usually the more sensible starting point. The goal at this stage is learning whether the product resonates with real customers, not protecting a proprietary formula that may need to change anyway based on early feedback. Locking into a full OEM development cycle before you’ve validated basic product-market fit risks sinking months of development time into a formula the market ultimately doesn’t want.
Scenario: an established brand adding a signature hero product
Once a brand has traction and a defined customer base, the calculation shifts. A hero product is often worth the additional time and cost of OEM development, because genuine formulation exclusivity becomes a real competitive moat once you have the distribution and marketing reach to make that differentiation matter commercially. This is typically where brands that started with ODM or private label transition a specific flagship SKU to a custom OEM formula.
Scenario: a brand expanding into a new export market
Brands adding a new country to their distribution footprint should factor regulatory readiness into the model decision, not just cost and speed. Some ODM and OEM factories have more export documentation experience with specific markets than others, and that experience can meaningfully shorten your registration timeline. A factory well versed in preparing documentation for, say, ASEAN Cosmetic Directive compliance or FDA OTC monograph alignment may be worth prioritising over a marginally cheaper option with less export experience, regardless of which manufacturing model you ultimately choose.
Mixing models across a single product range
It’s worth normalising the idea that most mature cosmetics brands don’t run their entire catalogue under one model. A typical pattern looks like: private label or ODM for fast-moving, lower-margin items where speed and cost matter most; OEM reserved for one or two flagship formulas that carry the brand’s core identity. This mixed approach lets a brand manage cash flow and development risk without sacrificing the differentiation that matters most for the products customers associate the brand with.
Questions worth asking before you commit
Before signing with any manufacturer under any model, it helps to have clear answers to a short list of questions: What exactly do I own if I stop working with this factory — the formula, or nothing? What’s the realistic MOQ and does it match my current sales velocity? What certifications does this factory hold, and do they match my target export markets? And critically, what’s the factory’s answer if I ask whether this exact formula, or a close variant, is being sold to another brand?
Red flags to watch for during manufacturer conversations
Be cautious of any factory that is vague about formula exclusivity terms, unwilling to put certification claims in writing, or reluctant to provide references from existing clients. Similarly, a manufacturer who can’t give you a realistic MOQ and lead time range early in the conversation — and instead delays those numbers until after you’ve committed to a deposit — is worth treating carefully. These aren’t automatic disqualifiers on their own, but they warrant closer due diligence before you proceed.
Knowing when it’s time to switch models
It’s common, and not a sign of poor initial planning, for a brand to outgrow its starting model. A signal that it’s time to consider moving from ODM or private label to OEM for a given product is when that SKU becomes a meaningful revenue driver and you notice close formula lookalikes appearing from other brands sourcing the same factory catalogue. At that point, the cost of custom development is more easily justified by the volume and margin the product already generates.
Don’t underestimate the compliance layer
Whichever model you land on, remember that your manufacturing choice doesn’t substitute for market-entry regulatory work. In Malaysia, for example, cosmetic products — OEM, ODM or private label alike — must be notified to the National Pharmaceutical Regulatory Agency (NPRA) before they can legally be sold. Build this into your launch timeline from day one rather than treating it as a final formality once the product is already manufactured.
How manufacturer pricing structures differ across the three models
It helps to understand not just the total cost difference between OEM, ODM and private label, but where that cost actually sits in a factory’s pricing structure. Private label pricing is typically a straightforward per-unit cost with minimal or no separate development fee, since the product formulation is already amortised across many brand clients. ODM pricing usually includes a smaller development or customisation fee on top of the per-unit cost, covering the work of adapting an existing base formula to your specific fragrance, colour or minor ingredient requests. OEM pricing tends to separate development cost from production cost entirely — you may pay a dedicated formulation development fee upfront, calculated independently of your eventual order volume, with per-unit production cost only kicking in once the formula is finalised and the first commercial batch is scheduled.
Understanding this structure matters when you’re comparing quotes between manufacturers, because a lower per-unit price from one factory can be offset by a much higher development fee, and vice versa. Ask every manufacturer to break down their quote into development cost and production cost separately, rather than accepting a single bundled number, so you can compare like with like across different factories and models.
For a breakdown of what each model actually means in practice, see OEMReview’s guide to OEM, ODM and Private Label in Cosmetics, or browse the full OEM Knowledge archive for more on formulation, compliance and manufacturer selection.
Frequently asked questions
Is there a “best” model among OEM, ODM and private label?
No single model is universally best. The right choice depends on your budget, timeline, and how much differentiation the specific product needs at your brand’s current stage. Many successful brands use a mix of all three across different products in their range.
Should a first-time brand owner avoid OEM entirely?
Not necessarily avoid, but most first-time brand owners are better served starting with ODM or private label to validate demand before committing to the longer timeline and higher cost of full OEM development. OEM becomes more attractive once you have evidence the product category will sell.
How do I know if my product needs OEM-level exclusivity?
Ask whether the product is meant to be a defining part of your brand identity, or a supporting item in a wider catalogue. Hero products that anchor your positioning usually justify OEM investment; supporting or seasonal items often perform fine under ODM or private label.
Can I switch from ODM to OEM later for the same product?
Yes, this is a common growth pattern. Brands frequently start a product under ODM to launch quickly, then transition to a custom OEM formula once the product proves its sales volume and the investment in exclusivity becomes commercially justified.
This guide is provided for informational purposes only and is not a substitute for professional manufacturing, legal or regulatory advice. Always verify current terms directly with your manufacturing partner and relevant regulatory authority.
About the author
Kawee Chong is a Singapore-based health, wellness and consumer-product business executive with extensive experience in commercialisation, international sales, sourcing and business growth. His career spans finance, product sourcing, distribution and the development of health and beauty businesses across Asian markets. LinkedIn
